T1D Exchange facilitates and conducts research to serve a wide variety of needs within type 1 diabetes care, technology, medication, insurance, and more.
In order to identity the most effective ways to improve outcomes and quality of life for people with T1D, we have built extensive partnerships in the research community via our Quality Improvement Collaborative (T1DX-QI), our Registry cohort, and our Online Community.
These research partnerships have led to changes and improvements in diabetes care including increased insurance coverage for blood glucose meter strips, changes in American Diabetes Association guidelines for pediatric A1c goals, FDA expansion of Dexcom CGM labeling to include finger stick replacements, and Medicare coverage of CGM devices.
T1D Exchange resources to develop and populate research includes:
The Registry: Over 18,000 participants living with or affected by T1D populate studies managed by our Registry team. These participants have filled out detailed questionnaires to help populate studies based on features including age, ethnicity, technology use, type of insulin, years with T1D, and more.
The Quality Improvement Collaborative (T1DX-QI): The T1DX-QI consists of 54+ clinics across the United States treating over 85,000 people with type 1 diabetes and 20,000 with type 2 diabetes. The T1DX-QI strives to identify and improve critical aspects of patient care.
Custom Research: Our Custom Research team produces tailored studies populated by our Registry and/or Online Community to gain deeper insights into any aspect of living with and treating T1D — including medications, technology, patient care, quality of life, and more.
The Online Community: With a network of over 50,000 people affected by diabetes, our community answers daily questions about a wide range of diabetes-related topics and can be invited to participate in many other types of research studies.